Oct 2026· Journal of Stomatology Oral and Maxillofacial Surgery· Vol 127, pp.
103041
· 0 citations· 40 references
Medicine
TL;DR
XCL1 is associated with glycolysis-related metabolic alterations and OSCC cell growth in vitro, which support further investigation of XCL1 in OSCC, while in vivo studies and larger clinical cohorts are needed to further evaluate its biological and therapeutic relevance.
Abstract
Objective
Oral squamous cell carcinoma (OSCC) is a head and neck cancer with high morbidity and mortality. Glycolytic metabolism plays a crucial role in its progression, yet the molecular mechanisms regulating glycolysis in OSCC remain unclear.
Design
Single-cell RNA sequencing of the GSE247582 dataset was used to identify cell subsets, analyze metabolic pathway enrichment, and screen core candidate genes. TCGA data were used to validate gene expression. In vitro gain- and loss-of-function experiments, together with glycolysis inhibition, were performed to assess the effects of XCL1 on cell proliferation, apoptosis, and glycolysis-related metabolic parameters.
Results
Five cellular subgroups were identified, each with distinct metabolic characteristics. The glycolysis/gluconeogenesis pathway was markedly active in specific subsets. Fifteen candidate genes were identified through differential expression analysis, of which seven were significantly upregulated in OSCC tissues in both paired and unpaired TCGA analyses. XCL1 showed the most pronounced and consistent upregulation among the validated candidates and was selected for functional investigation. XCL1 knockdown significantly suppressed OSCC cell proliferation, induced apoptosis, and reduced glucose uptake, lactate production, ATP levels, LDH activity, and the expression of glycolytic enzymes, including HK2, PKM2, and LDHA. Conversely, XCL1 overexpression enhanced OSCC cell proliferation and glycolysis-related metabolic parameters and reduced apoptosis, whereas 2-DG attenuated these effects.
Conclusions
XCL1 is associated with glycolysis-related metabolic alterations and OSCC cell growth in vitro. These findings support further investigation of XCL1 in OSCC, while in vivo studies and larger clinical cohorts are needed to further evaluate its biological and therapeutic relevance.
Background/Objectives: Myeloid-derived suppressor cells (MDSCs) play an essential role in tumor immune evasion from the immune system; however, the common molecular signatures associated with MDSCs across different cancer types remain limited. This study aimed to identify and validate common MDSC-associated hub genes a...
Maysa M. Abosenna, Ahmed Osman, Ahmed M. R. Fath El-Bab et al.· Immuno· 0 citations
The oncogenic ELFN1-AS1/LYPLA1 regulatory cascade is characterized as a potential biomarker and therapeutic target for precision management of osteosarcoma and establishes an LMRL-based for osteosarcoma prognostic stratification that reflects immune, genomic and therapeutic heterogeneity.
Xian-Fu Wei, Zhi-Peng Wang, Qiang Yang et al.· Frontiers in Immunology· 0 citations
Cholangiocarcinoma is a relatively uncommon cancer, accounting for approximately 3% of all gastrointestinal malignancies. However, its global incidence has been steadily rising over the past few decades, and the precise factors driving this increase remain unclear. This study aimed to identify prognosis-related c...
Xi-Fan Wang, Wei V. Zheng, Gai-Li An et al.· BMC Gastroenterology· 0 citations
Background Gemcitabine (GEM) resistance limits treatment efficacy in bladder cancer (BC). This study identified MAN1B1 as a key driving factor for chemotherapy resistance and malignant progression in BC. Methods Bulk-RNA datasets GSE190636 and single-cell RNA-seq dataset GSE250523 from GEO. Use limma package to identif...
Ming-Zhe Jiang, Dong Zhao, Liang Zhang et al.· Frontiers in Immunology· 0 citations
BACKGROUND
Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with limited prognostic biomarkers, in which metabolic reprogramming contributes to tumor progression. Amino acid transporters of the solute carrier family have emerged as key regulators of cancer biology; however, the role of solute carrier fam...
Lilianny Querino R. de Oliveira, E. F. de Morais, Cintia Eliza Marques et al.· Journal of Oral Pathology &...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.